Anti-GPC1 mAb induced significant tumor growth inhibition in ESCC xenograft models via antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) dependent and independent manner. This evidence concerns the gene GPC1 and esophageal squamous cell carcinoma.